Ms. Hathaway prepares and prosecutes applications for United States and foreign filing, and advises clients regarding patentability, freedom to operate, and drug patent life cycle management to minimize innovator and generic competition and maximize regulatory exclusivity. Ms. Hathaway also has experience in IP transactional support including due diligence investigation and presentation. Ms. Hathaway’s clients include large and small pharmaceuticals companies, universities, start-ups, and sole inventors. Prior to joining Global Patent Group, Ms. Hathaway was an agent and intellectual property department liaison at Kalypsys, where she tactically managed the rapid growth of the patent estate and supported joint research programs with major pharmaceuticals partners.